⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7129361 | 0.97 | LTA4H (0.43) | — | |
| SCHEMBL410120 | 0.90 | LTA4H (0.57) | — | |
| Butane SCHEMBL20590981 | 0.88 | LTA4H (0.41) | — | |
| SCHEMBL819908 | 0.85 | MMP3 (0.44) | — | |
| SCHEMBL14477632 | 0.84 | MEN1 (0.33) | — | |
| SCHEMBL30602838 | 0.79 | LTA4H (0.38) | — | |
| Acrylamide SCHEMBL1723260 | 0.79 | THRB (0.41) | — | |
| SCHEMBL78443 | 0.79 | MRGPRX4 (0.41) | — | |
| SCHEMBL14926316 | 0.79 | ALDH1A1 (0.45) | — | |
| SCHEMBL17577288 | 0.79 | ESR1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3054 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4269578-B1 | SOLUBLE HYALURONIDASE COMPOSITION | HALOZYME INC (US) | 2024-06-05 | — | — | EP | claimed |
| US-11702452-B2 | Process for making arylomycin ring analogs | GENENTECH, INC. (US) | 2023-07-18 | — | — | US | claimed |
| EP-3458442-B1 | SYNTHESIS OF 6-ARYL-4-AMINOPICOLINATES AND 2-ARYL-6-AMINOPYRIMIDINE-4-CARBOXYLATES BY DIRECT SUZUKI COUPLING | CORTEVA AGRISCIENCE LLC (US) | 2022-12-28 | — | — | EP | claimed |
| US-20220056078-A1 | PROCESS FOR MAKING ARYLOMYCIN RING ANALOGS | GENENTECH, INC. (US) | 2022-02-24 | — | — | US | claimed |
| US-11192924-B2 | Process for making arylomycin ring analogs | GENENTECH, INC. (US) | 2021-12-07 | — | — | US | claimed |
| EP-3601240-B1 | PROCESS FOR MAKING ARYLOMYIN RING ANALOGS | HOFFMANN LA ROCHE (CH) | 2021-08-04 | — | — | EP | claimed |
| CN-105169398-B | Controlled release system based on mesoporous silicon oxide nano particles and preparation method thereof | 华东理工大学 | 2020-08-18 | — | — | CN | claimed |
| US-20200255476-A1 | PROCESS FOR MAKING ARYLOMYCIN RING ANALOGS | GENENTECH, INC. (US) | 2020-08-13 | — | — | US | claimed |
| US-10662333-B2 | NIR long lifetime indicator molecule | PROFUSA, INC. (US) | 2020-05-26 | — | — | US | claimed |
| EP-3601240-A1 | PROCESS FOR MAKING ARYLOMYIN RING ANALOGS | H. Hoffnabb-La Roche Ag (CH) | 2020-02-05 | — | — | EP | claimed |
| WO-2006091871-A1 | SOLUBLE GLYCOSAMINOGLYCANASES AND METHODS OF PREPARING AND USING SOLUBLE GLYCOSAMINOGLYCANASES | HALOZYME THERAPEUTICS, INC. (US) | 2006-08-31 | — | — | WO | claimed |
| US-20060104968-A1 | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases | HALOZYME, INC. (US) | 2006-05-18 | — | — | US | claimed |
| US-7041280-B2 | Aryl boronate functionalized polymers for treating obesity | GENZYME CORPORATION (US) | 2006-05-09 | — | — | US | claimed |
| EP-1603541-A2 | SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF | Halozyme, Inc. (US) | 2005-12-14 | — | — | EP | claimed |
| US-20050260186-A1 | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases | HALOZYME, INC. (US) | 2005-11-24 | — | — | US | claimed |
| US-20040268425-A1 | use to treat glycosaminoglycan associated pathologies such as eye disorders or tumors; sialated and pegylated forms of a recombinant sHASEGP to enhance stability and serum pharmacokinetics over naturally occurring slaughterhouse enzymes; transgenic animals; dosage forms | DELIATROPH PHARMACEUTICALS, INC. | 2004-12-30 | — | — | US | claimed |
| WO-2004078140-A2 | SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF | HALOZYME, INC. (US) | 2004-09-16 | — | — | WO | claimed |
| EP-1404686-A1 | ARYL BORONATE FUNCTIONALIZED POLYMERS FOR TREATING OBESITY | Geltex Pharmaceuticals, Inc. (US) | 2004-04-07 | — | — | EP | claimed |
| US-20030059399-A1 | Aryl boronate functionalized polymers for treating obesity | GELTEX PHARMACEUTICALS, INC. | 2003-03-27 | — | — | US | claimed |
| WO-2003002571-A1 | ARYL BORONATE FUNCTIONALIZED POLYMERS FOR TREATING OBESITY | GENZYME CORPORATION (US) | 2003-01-09 | — | — | WO | claimed |